维普中文期刊产品整合服务
21篇 您的检索式:作者名="Guzzetta NA"
    题名 作者 年代 出处 被引量
1Tissue factor-activated thromboelastograms in children undergoing cardiac surgery:baseline values and comparisons显示文摘Miller BE Guzzetta NA Tosone SR 2003Anesth Analg2003,97,5:1
2An evaluation of the effects of standard heparin dose on thrombin inhibition during cardiopulmonary bypass in neonates显示文摘Guzzetta NA Miller BE Todd K 2005Anesth Analg2005,100,5:1
3Clinical measures of heparin's effect and thrombin inhibitor levels in pediatric patients with congenital heart disease显示文摘Guzzetta NA Miller BE Todd K 2006Anesth Analg2006,103,5:1
4An evaluation of effects of a standard heparin dose on thrombin inhibition during cardiopulmonary bypass in neonate显示文摘Guzzetta NA Miller BE Todd K 2005Anesth Analg2005,100,5:1
5Fibrinogen in children undergoing cardiac surgery:is it effective?显示文摘Miller BE Tosone SR Guzzetta NA 2004Anesth Analg2004,99,5:1
6Benefits and risks of red blood cell transfusion in pediatric patients undergoing cardiac surgery 显示文摘Guzzetta NA 2011Paediatr An- aesth2011,21,5:1
7Principles of hemostasis in children:models and maturation显示文摘Guzzetta NA Miller BE 2011Paediatr Anaesth2011,21,1:1
8Rapid evaluation of coagulopathies after caudiopulmonary bypass in children using modified thrombolastogrphy 显示文摘ller BE Guzzetta NA Tosone SR 2000Anesth - Analg2000,90,6:1
9Correlations be-tween activated clotting time values and heparin concentration meas- urements in young infants undergoing cardiopulmonary bypass 显示文摘Guzzetta NA Monitz HG Fernandez JD 2010Anesth Analg2010,111,:1
10Benefits and risks of red blood cell transfusion in pediatric patients undergoing cardiac surgery显示文摘Guzzetta NA 2011Paediatr Anaesth2011,21,5:1
11Fibrinogen in children undergoing cardiac surgery: is it effective? 显示文摘Miller BE Tosone SR Guzzetta NA 2004Anesth Analg2004,99,5:1
12Fibrinog en in children undergoing cardiac surgerysis it effective 显示文摘Miller BE Tosone SR Guzzetta NA 2004Anesth Analg2004,99,5:1
13Clinical measures of heparin's effect and thrombin inhibitor levels in pedi-atric patients with congenital heart disease 显示文摘Guzzetta NA Miller BE Todd K 2006Anesth Analg2006,103,5:1
14Phenoxybenzamine in the treatment of hypoplastic left heart syndrome: a core review显示文摘Guzzetta NA 2007Anesth Analg2007,105,2:1
15Correlations between activated clotting time values and heparin con-centration measurements in young infants undergoing car-diopulmonary bypass 显示文摘Guzzetta NA Monitz HG Fernandez JD 2010Anesth Analg2010,111,1:1
16A comparison of hepa- rin omnagement strategies in infants undergoing cardiopulmo- nary bypass 显示文摘Guzzetta NA Bajaj T Fazlollah T 2008Anesth Analg2008,106,:1
17Fibringen in children undergoing cardiac surgery: is it effective? 显示文摘Miler BE Tosone SR Guzzetta NA 2004Anesth Analg2004,99,5:1
18Benefits and risks of red blood cell transfusion in pediatric patients undergoing cardiac surgery 显示文摘Guzzetta NA 2011Paediatr Anaesth2011,21,5:1
19Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass显示文摘Guzzetta NA Monitz HG Fernandez JD 2010Anesth Analg2010,111,1:1
20An evaluation of the effects of a standard heparin dose on thmmbin inhibition during cardiopulmonary bypass in neonates显示文摘 MiHer BE Todd K 2005Anesth Analg2005,100,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费